In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...

Journal Editorial Report: Paul Gigot interviews Jason Riley about his new book. Derrick Bell is best known for his contributions to critical race theory—which claims that racism is embedded in ...

During a live event, Ahmad Tarhini, MD, PhD, discussed the RELATIVITY-047 trial of nivolumab/relatlimab vs nivolumab alone in ...

The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of disease. Research in this area is vital for designing ...

Interestingly, Channi, apparently alluding to the Balakot bombings, claimed that the action after Pulwama did not happen as nobody saw anything. A meeting of the CWC reiterated the demand for ...

To curate this list, he dives into Max’s catalogue every month to surface exciting, white-knuckle action titles — using his taste and a lifetime of cinema study as his guide, instead of ...

Other candidates include anti-BDCA2 antibody litifilimab in phase 3 for SLE ... is that impacting the CD40L pathway, a central mechanism in immune response, would translate to significant impact ...

On February 20, Jared […] Royalty Pharma to provide R&D investment of up to $250 million for Biogen’s litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment ...

The Federal Court has rejected the federal government's motion to dismiss a claim for monetary relief in a class-action lawsuit brought by non-status individuals and Métis who were involved in ...

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports Action.